<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04231786</url>
  </required_header>
  <id_info>
    <org_study_id>2019.05.122</org_study_id>
    <nct_id>NCT04231786</nct_id>
  </id_info>
  <brief_title>Breast Ultrasonography and Polycystic Ovary Syndrome</brief_title>
  <official_title>Breast Ultrasonography Findings in Patients Over 30 Years With Polycystic Ovary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kanuni Sultan Suleyman Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kanuni Sultan Suleyman Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The results of the evaluation of breast ultrasonography results of patients with polycystic
      ovary syndrome diagnosis over 30 years of age will be evaluated.

      Patients admitted to the outpatient clinic and rotterdam criteria according to laboratory
      data and polycystic ovary syndrome patients diagnosed by the same radiologist the next day
      after the end of menstrual breast ultrasonography. The aim of this study is to show the
      association of polycystic ovary syndrome and fibrocystic breast.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 14, 2020</start_date>
  <completion_date type="Anticipated">June 14, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 14, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Breast ultrasonography findings</measure>
    <time_frame>1 month</time_frame>
    <description>Breast ultrasonography findings in patients over 30 years of age diagnosed with polycystic ovary syndrome. THE PRESENCE OF FIBROCISTIC DISEASE WILL BE EVALUATED FOR FIBROADENOMA OR OTHER BREAST DISEASE. YES OR NO ; WILL BE REGISTERED.</description>
  </primary_outcome>
  <enrollment type="Actual">1</enrollment>
  <condition>Breast Diseases</condition>
  <condition>Polycystic Ovary</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Breast ultrasonography findings</intervention_name>
    <description>Breast ultrasonography findings in patients over 30 years of age diagnosed with polycystic ovary syndrome.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients over 30 years of age diagnosed with polycystic ovary syndrome breast
        ultrasonography findings in these patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 30 years

          -  diagnosed with polycystic ovary syndrome according to rotterdam criteria

          -  no previous history of breast disease

          -  female patients

        Exclusion Criteria:

          -  Under 30 years

          -  polycystic ovary syndrome

          -  patients with a previously known history of breast disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kanuni Sultan Süleyman Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>33404</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>January 14, 2020</study_first_submitted>
  <study_first_submitted_qc>January 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>May 21, 2020</last_update_submitted>
  <last_update_submitted_qc>May 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kanuni Sultan Suleyman Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Pınar Kadirogulları</investigator_full_name>
    <investigator_title>Pınar Kadiroğulları M.D, Department of Obstetrics and Gynecology,Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>breast diseases</keyword>
  <keyword>fibrocystic breast</keyword>
  <keyword>polycystic ovari syndrome</keyword>
  <keyword>fibroadenoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Breast Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

